Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and …
$62.95-2.48%
报价 2026-11-13
市值
$3.09B
EV
$4.9B
PE (TTM)
24.2x
预期 PE (FY2026)
16.2x
52 周区间距高点 -30.8%
$62.95$91.02
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-13未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 0.6x | 14.29 → 3.22（0.2x） | 19.6 |
| FY+32028-12 | 0.6x | 14.29 → 3.24（0.2x） | 19.4 |
毛利率 61% · TTM 收入 $457M · 基数 EPS 14.29（调整后）
收入口径存疑
电话会信号
辅助标签Q3 20262026-11-10
下调/撤回指引
指引 下调
信心 3
分析师 2
“We expect 2026 to be our second largest investment year in the company's history.”
原文引用（1）
- 下调/撤回指引：we revised our full year guidance to a range of $4.68 to $4.70 per share
蓝色标签在暴涨研究中略有区分度；悬停查看口径。
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NHINational Health Investors, Inc. | $3.09B | -2.5% | +4.5% | 31.1% | 24.2x | 16.9x | 16.2x | |
| PSAPublic Storage | $62.14B | -0.2% | +7.5% | 72.1% | 27.3x | 18.7x | 16.8x | |
| VNOVornado Realty Trust | $6.49B | -1.4% | +2.3% | 100% | 5.5x | 6.8x | 32.7x | Cheap |
| SBRASabra Health Care REIT, Inc. | $5.35B | +0.9% | +25.7% | 58.7% | 74.9x | 19.1x | 15.3x | GARP |
| EPREPR Properties | $4.61B | +2.1% | +11.3% | 41.9% | 19.5x | 13.6x | 11.2x | GARP |
| CDPCOPT Defense Properties | $3.76B | +1.3% | +7.8% | 25.6% | 23.3x | 15.0x | 16.7x | |
| BNLBroadstone Net Lease, Inc. | $3.38B | +0.7% | +9.0% | 23.5% | 35.4x | 16.5x | 12.2x | |
| CWKCushman & Wakefield plc | $3.12B | -1.4% | +58.3% | 17.3% | 49.9x | 10.7x | 14.7x | |
| ABRArbor Realty Trust, Inc. | $235.7M | -1.5% | -14.2% | 92.2% | 10.0x | 13.1x | 0.7x | |
| 同行中位数 | – | – | +8.4% | 50.3% | 25.3x | 14.3x | 15.0x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 | 2024-09-30 Q3 2024 | 2024-06-30 Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $115.9M | $106.5M | $89.8M | $90.7M | $89.3M | $85.8M | $82.9M | $85M |
| Gross Margin | 31.1% | 33.6% | 97.1% | 96.8% | 96.8% | 96.7% | 96.6% | 96.7% |
| Operating Margin | 45.2% | 47.2% | 49.1% | 53.7% | 53.6% | 50% | 56.1% | 57.9% |
| Net Income | $40.1M | $38.2M | $32.9M | $37M | $34.2M | $43.2M | $28.5M | $35.3M |
| Diluted EPS | 0.82 | 0.8 | 0.69 | 0.79 | 0.74 | 0.95 | 0.65 | 0.81 |
| Operating Cash Flow | $53.4M | $69.4M | $62.6M | $61.3M | $46.9M | $57.6M | $48.6M | $61M |